John K. Whisnant, Jr, MD

Giora Davidai, MD


A practicing Pediatric Nephrologist from 1978 to 1993. Dr. Davidai obtained his M.D. degree at the Sackler School of Medicine, University of Tel Aviv, Israel, and completed residency training in Pediatrics at Rothchild Hospital, Haifa, Israel, a fellowship in Nephrology at Rambam Hospital, Haifa, Israel, and a Pediatric Nephrology fellowship at Duke University North Carolina.  He stayed as faculty at Duke and received an adjunct professorship at Bowman Grey Medical School, Winston Salem, North Carolina for a teaching position.  He is an author of numerous peer- reviewed articles and lectured in many conferences.

Since 1990 Dr. Davidai worked in the pharmaceutical industry at all stages of drug development, from molecule to market. He joined the pharmaceutical industry in order to build a new global bone research team in Glaxo Welcome concentrating on Osteoporosis.  After four years in R&D joined the medical department in GW and helped develop Imitrex and Naramig for Migraine Headache and after their launch became the Global Head of Headache Migraine and Epilepsy clinical development until 1998. 

Giora served as Executive Director and Head of the Cardiovascular, Metabolic, CNS and Pulmonary departments at Boehringer Ingelheim from 2000 – 2011.  During this time he oversaw the development and launch of Mirapex XR, Micardis, Micardis HCT, Twynsta, Linagliptin, and Pradaxa.  From 2011-2016 he was the head of the Established Products Department in Clinical Development and Medical Affairs in BI.

 

Click here to see consultant’s profile

Leadership List

Officers

G. Alexander Fleming, MD
Executive Chairman

Thomas Seoh
President and Chief Executive Officer

 

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Grant Williams, MD

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Peter Damsbo, MD

Richard Paul, MD

Rob Walsh, MD

Simon Bruce, MD

Theo Gana, MD, Ph.D

Todd J. Lorenz, MD

 

Regulatory Affairs

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

Dia Hill

Doug Muchmore, MD

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Grant Williams, MD

Joshua Sharlin, Ph.D

Joyce Reyes

Lana Pauls, MPH

Michael Sharp, Ph.D

Scot Faulkner, MPA

 

EU Regulatory

Catherine Bernard, Ph.D

Michael Trautmann, MD

 

Clinical Operations/Project Management

Chris Yun

Diane Paul, MS, RN

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lana Pauls, MPH

Lynn Schaich

Susan Manley

 

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Marijke Adams PharmD, Ph.D

Monalisa Chatterji,Ph.D

Virgil Whitehurst, Ph.D

 

CMC, Formulation/Process Development & Sourcing

Anand Khedkar, Ph.D

David Bergstrom, Ph.D

Joyce Reyes

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

 

Medical Device

Michael Sharp, Ph.D

Rob Walsh, MD

 

 QA/QC

Joshua Sharlin, Ph.D

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lynn Schaich

Robert Kaster, RPh., ASQ-CQA

 

Medical Writing/Electronic Submissions

Brandon Jones

Dahlia Sperling

Russ Neubauer, Ph.D

Sandor Bernath, Ph.D, MBA

 

Process & Innovation Management

Elizabeth Whalley Buono, BSN, RN, MBA, JD

Scot Faulkner, MPA

 

Commercializing and Business & Corporate Strategy

Lisa Jansa, MBA

Martin Lafontaine

Stephen Casey, MBA

Thomas Seoh

 

Founders

G. Alexander Fleming, MD

Lisa Jansa, MBA